Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images

Multiplex imaging technologies are now routinely capable of measuring more than 40 antibody-labeled parameters in single cells. However, lateral spillage of signals in densely packed tissues presents an obstacle to the assignment of high-dimensional spatial features to individual cells for accurate...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 12; p. 652631
Main Authors: Bai, Yunhao, Zhu, Bokai, Rovira-Clave, Xavier, Chen, Han, Markovic, Maxim, Chan, Chi Ngai, Su, Tung-Hung, McIlwain, David R, Estes, Jacob D, Keren, Leeat, Nolan, Garry P, Jiang, Sizun
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 05-07-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiplex imaging technologies are now routinely capable of measuring more than 40 antibody-labeled parameters in single cells. However, lateral spillage of signals in densely packed tissues presents an obstacle to the assignment of high-dimensional spatial features to individual cells for accurate cell-type annotation. We devised a method to correct for lateral spillage of cell surface markers between adjacent cells termed REinforcement Dynamic Spillover EliminAtion (REDSEA). The use of REDSEA decreased contaminating signals from neighboring cells. It improved the recovery of marker signals across both isotopic (i.e., Multiplexed Ion Beam Imaging) and immunofluorescent (i.e., Cyclic Immunofluorescence) multiplexed images resulting in a marked improvement in cell-type classification.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors share senior authorship
Reviewed by: Ellis Patrick, The University of Sydney, Australia; Barbara Rolfe, The University of Queensland, Australia
These authors have contributed equally to this work
Edited by: Katy Rezvani, University of Texas MD Anderson Cancer Center, United States
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.652631